Rizatriptan Benzoate API Market Size and Emerging TrendsMylan, Inke S.A, Jai Radhe Sales - UMD Statesman
| 1777 Stock | TWD 95.00 0.30 0.31% |
Slightly above 61% of SYN Tech's investor base is looking to short. The analysis of current outlook of investing in SYN Tech Chem Pharm suggests that many traders are alarmed regarding SYN Tech's prospects. SYN Tech's investing sentiment can be driven by a variety of factors including economic data, SYN Tech's earnings reports, geopolitical events, and overall market trends.
SYN Tech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of SYN daily returns and investor perception about the current price of SYN Tech Chem Pharm as well as its diversification or hedging effects on your existing portfolios.
SYN |
Rizatriptan Benzoate API Market Size and Emerging TrendsMylan, Inke S.A, Jai Radhe Sales UMD Statesman
Read at news.google.com
 |
SYN Tech Fundamental Analysis
We analyze SYN Tech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SYN Tech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SYN Tech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
SYN Tech is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
SYN Tech Chem Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SYN Tech stock to make a market-neutral strategy. Peer analysis of SYN Tech could also be used in its relative valuation, which is a method of valuing SYN Tech by comparing valuation metrics with similar companies.
Peers
SYN Tech Related Equities
| 2881 | Fubon Financial | 2.51 | ||||
| 2006 | Tung Ho | 0.99 | ||||
| 2228 | Iron Force | 0.96 | ||||
| 2884 | ESUN Financial | 0.18 | ||||
| 2852 | First Insurance | 0.20 | ||||
| 5210 | APEX International | 1.33 |
Additional Tools for SYN Stock Analysis
When running SYN Tech's price analysis, check to measure SYN Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SYN Tech is operating at the current time. Most of SYN Tech's value examination focuses on studying past and present price action to predict the probability of SYN Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SYN Tech's price. Additionally, you may evaluate how the addition of SYN Tech to your portfolios can decrease your overall portfolio volatility.